| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Fibroblasts Induced by a Specific Inhibitor of Cyclic Adenosine 3':5'-Phosphodiesterase1
Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, New York 14263
This study was conducted to further characterize the previously described phenomenon of growth inhibition of neoplastically transformed C3H/10T
cells (T10T
) by nontransformed C3H/10T
clone 8 mouse embryo fibroblast (10T
) cells in the presence of inhibitors of cyclic adenosine 3':5'-monophosphate (cAMP) phosphodiesterase. The cAMP phosphodiesterase inhibitor di-4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO20-1724) was shown to be completely nontoxic to T10T
cells at 10-4 M. yet when added to mixed cultures of T10T
cells and postconfluence growth-arrested 10T
cells, colony formation and [3H]thymidine incorporation into T10T
cells were virtually eliminated. This effect was dose dependent and was reversible upon drug withdrawal. In 10T
cells, RO20-1724 caused a dose-dependent increase in cAMP levels from about 5 to 150 pmol/106 cells; in T10T
cells, 10-4 M drug treatment caused a 5-fold elevation in cAMP without a clear dose dependency. Cyclic guanosine 3':5'-monophosphate levels in 10T
cells fell by 50% with drug treatment but were unmeasurable in T10T
cells. When intracellular cyclic AMP levels were elevated by the adenyl cyclase stimulator forskolin, growth inhibition of T10T
cells was again induced in mixed cultures but was not observed when added to T10T
cells alone. Addition of RO20-1724 to low concentrations of forskolin produced a greater than additive effect on growth inhibition. Growth inhibition of T10T
cells by RO20-1724 was shown to (a) require contact with, or extremely close proximity to, a confluent monolayer of 10T
cells, (b) be maximum when seeded upon a growth-inhibited monolayer and not an actively growing 10T
culture, and (c) not be decreased by continuous agitation of the culture medium, indicating that readily diffusible inhibitory factors are not involved. A model is presented whereby transformed cells can respond to but cannot themselves generate growth-inhibitory signals produced by post-confluence growth-inhibited nontransformed cells. The existence of these cellular interactions may well explain problems in the quantitation of transformed foci encountered in the use of this cell line as an assay system for chemical and physical carcinogens.
1 This investigation was supported by USPHS Grant CA 21359 and Core Grant CA 24538 awarded by the National Cancer Institute, Department of Health and Human Services.
2 Present address: Cancer Research Center of Hawaii, 1236 Lauhala St., Honolulu, HI 96813.
Received 8/30/83. Revised 10/31/84. Accepted 1/24/85.
This article has been cited by other articles:
![]() |
T. J. King, L. H. Fukushima, A. D. Hieber, K. A. Shimabukuro, W. A. Sakr, and J. S. Bertram Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression Carcinogenesis, June 1, 2000; 21(6): 1097 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Herschman and D. Brankow Ultraviolet irradiation transforms C3H10T1/2 cells to a unique, suppressible phenotype Science, December 12, 1986; 234(4782): 1385 - 1388. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |